A shift in the balance of regulatory T and T helper 17 cells in rheumatic heart disease

Journal of Investigative Medicine

Volumn 62, Issue 1, 2014, Pages 78-83

  Bas, Hatice Duygu ^a   Baser, Kazim ^a   Yavuz, Emine ^a   Bolayir, Hasan Ata ^a   Yaman, Belma ^a   Unlu, Serkan ^a   Cengel, Atiye ^a   Bagriacik, Emin Umit ^a   Yalcin, Ridvan ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Autoimmunity; Rheumatic heart disease

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FUNCTIONAL STATUS; HUMAN; HUMAN CELL; IMMUNITY; MALE; MITRAL VALVE DISEASE; REGULATORY T LYMPHOCYTE; RHEUMATIC HEART DISEASE; TH17 CELL; TH17 REGULATORY T LYMPHOCYTE RATIO; TRANSTHORACIC ECHOCARDIOGRAPHY; ULTRASOUND SCANNER; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE STENOSIS; PROTEIN BLOOD LEVEL;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; RHEUMATIC HEART DISEASE; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; YOUNG ADULT;

EID: 84896786421     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0000000000000023     Document Type: Article

References (44)

1. Carapetis JR, Steer AC, Mulholland E.K., et al. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005; 5: 685-694.
2. Marijon E, Mirabel M, Celermajer D.S., et al. Rheumatic heart disease. Lancet. 2012; 379: 953-964.
3. Tandon R, Sharma M, Chandrashekhar Y., et al. Revisiting the pathogenesis of rheumatic fever and carditis. Nat Rev Cardiol. 2013; 10: 171-177.
4. Cunningham MW. Streptococcus and rheumatic fever. Curr Opin Rheumatol. 2012; 24: 408-416.
5. Park H, Li Z, Yang X.O., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005; 6: 1133-1141.
6. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005; 6: 1123-1132.
7. H17 and regulatory T cells. Nature. 2006; 441: 235-238.
8. Veldhoen M, Hocking RJ, Atkins C.J., et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006; 24: 179-189.
9. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003; 299: 1057-1061.
10. H17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis. Rheumatology (Oxford). 2009; 48: 602-606.
11. + Tregs in regulation of inflammation and autoimmunity. Front Biosci. 2010; 15: 986-1006.
12. H17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum. 2009; 60: 1472-1483.
13. Nistala K, Moncrieffe H, Newton K.R., et al. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum. 2008; 58: 875-887.
14. H17 differentiation by group A streptococcal infection. Proc Natl Acad Sci U S A. 2010; 107: 5937-5942.
15. Yen D, Cheung J, Scheerens H., et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest. 2006; 116: 1310-1316.
16. H17 cytokines in skin lesions of patients with psoriasis. J Huazhong Univ Sci Technol Med Sci. 2007; 27: 330-332.
17. Al-Ramli W., Prefontaine D, Chouiali F., et al. T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol. 2009; 123: 1185-1187.
18. Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J. 2006; 27: 136-149.
19. Baumgartner H, Hung J, Bermejo J., et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009; 22: 1-23; quiz 101-102.
20. Zoghbi WA, Enriquez-Sarano M, Foster E., et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003; 16: 777-802.
21. Wilkins GT, Weyman AE, Abascal V.M., et al. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J. 1988; 60: 299-308.
22. Raizada V, Williams RC Jr, Chopra P, et al. Tissue distribution of lymphocytes in rheumatic heart valves as defined by monoclonal anti-T cell antibodies. Am J Med. 1983; 74: 90-96.
23. Kemeny E, Grieve T, Marcus R., et al. Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clin Immunol Immunopathol. 1989; 52: 225-237.
24. El-Demellawy M., El-Ridi R, Guirguis N.I., et al. Preferential recognition of human myocardial antigens by T lymphocytes from rheumatic heart disease patients. Infect Immun. 1997; 65: 2197-2205.
25. Guilherme L, Oshiro SE, Fae K.C., et al. T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients. Infect Immun. 2001; 69: 5345-5351.
26. + T helper cells. Cell. 2006; 126: 1121-1133.
27. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med. 2003; 198: 1875-1886.
28. Zhou L, Lopes JE, Chong M.M., et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature. 2008; 453: 236-240.
29. Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol. 2008; 9: 641-649.
30. + T cells in rheumatic mitral stenosis. J Heart Valve Dis. 2007; 16: 461-467.
31. Chiu-Braga Y.Y., Hayashi SY, Schafranski M, et al. Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP). Int J Cardiol. 2006; 109: 275-276.
32. Golbasi Z, Ucar O, Keles T., et al. Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation. Eur J Heart Fail. 2002; 4: 593-595.
33. Zizzo G, De Santis M, Bosello SL, et al. Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. Clin Immunol. 2011; 138: 107-116.
34. +CD25(high) CD127(low/j) Treg cell frequency from peripheral blood correlates with disease activity in patients with rheumatoid arthritis. J Rheumatol. 2011; 38: 2517-2521.
35. Gerber MA, Baltimore RS, Eaton C.B., et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2009; 119: 1541-1551.
36. Remenyi B, Carapetis J, Wyber R., et al. Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol. 2013; 10: 284-292.
37. Marijon E, Ou P, Celermajer D.S., et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007; 357: 470-476.
38. Carapetis JR, Hardy M, Fakakovikaetau T., et al. Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren. Nat Clin Pract Cardiovasc Med. 2008; 5: 411-417.
39. Roberts K, Colquhoun S, Steer A., et al. Screening for rheumatic heart disease: current approaches and controversies. Nat Rev Cardiol. 2013; 10: 49-58.
40. Hallorimsson J. Chronic rheumatic valvular heart disease. An autopsy study. Acta Pathol Microbiol Scand A. 1975; 83: 633-638.
41. Jacobson DL, Gange SJ, Rose N.R., et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997; 84: 223-243.
42. Fairweather D, Petri MA, Coronado M.J., et al. Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis. Expert Rev Clin Immunol. 2012; 8: 269-284.
43. Olsen I, Sollid LM. Pitfalls in determining the cytokine profile of human T cells. J Immunol Methods. 2013; 390: 106-112.
44. Baran J, Kowalczyk D, Ozog M., et al. Three-color flow cytometry detection of intracellular cytokines in peripheral blood mononuclear cells: comparative analysis of phorbol myristate acetate-ionomycin and phytohemagglutinin stimulation. Clin Diagn Lab Immunol. 2001; 8: 303-313.